“…The Zurich group has recently found that FMN, determined by fluorescence spectroscopy in HOPE perfusate, correlated with early graft loss, cumulative complications, and hospital stay after liver transplant [ 29 , 60 ]. Based on these observations, if the FMN concentration climbs above 8800 AU at 30 min of HOPE or a sharp incline is seen, the authors recommend not to transplant the liver; while for an intermediate release (8800–5000 AU), they suggest allocating the liver to a low-risk recipient [ 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 ]. Some other groups have confirmed the correlation of FMN with posttransplant liver function, and external validation of this method is currently ongoing [ 20 , 60 ].…”